TransMedics Group financial statements

트랜스메딕스 그룹NASDAQ:TMDX · Nasdaq · Healthcare · sector #17
$80.28-3.27%
2026-10-06 close

TransMedics Group's published financial data is dated 2026-10-04. 2024 revenue was $442M. 2024 operating profit was $37M.

Reported results

TransMedics Group notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q